True effect of monoclonal antibody for COVID-19 in kidney transplant recipients.
作者信息
Khatri Akshay, Raja Mohammed, Guerra Giselle, Natori Yoichiro
机构信息
Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine Miami, Miami, Florida, USA.
Miami Transplant Institute, Jackson Health System, Miami, Florida, USA.
出版信息
Am J Transplant. 2022 May;22(5):1492-1493. doi: 10.1111/ajt.16922. Epub 2021 Dec 18.
Abstract
摘要
相似文献
1
True effect of monoclonal antibody for COVID-19 in kidney transplant recipients.单克隆抗体对肾移植受者治疗新冠肺炎的真实疗效
Am J Transplant. 2022 May;22(5):1492-1493. doi: 10.1111/ajt.16922. Epub 2021 Dec 18.
2
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在肾移植受者中的持续存在情况。
Am J Transplant. 2021 Jun;21(6):2307-2310. doi: 10.1111/ajt.16469. Epub 2021 Jan 17.
3
Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.抗SARS-CoV-2单克隆抗体预防和疫苗接种对肾移植受者中新冠病毒奥密克戎变异株的疗效
Kidney Int. 2022 Aug;102(2):440-442. doi: 10.1016/j.kint.2022.05.007. Epub 2022 May 23.
4
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
5
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.COVID-19 患者肾移植受者中存活的 SARS-CoV-2 的长期脱落。
Am J Transplant. 2021 Aug;21(8):2871-2875. doi: 10.1111/ajt.16636. Epub 2021 Jun 18.
6
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.通过 SARS-CoV-2 变异株时代的肾移植受者中 COVID-19 的结局：抗 SARS-CoV-2 单克隆抗体的作用。
Transpl Int. 2022 Oct 4;35:10721. doi: 10.3389/ti.2022.10721. eCollection 2022.
7
COVID-19 after two doses of mRNA vaccines in kidney transplant recipients.肾移植受者接种两剂mRNA疫苗后的新冠病毒感染情况。
Am J Transplant. 2021 Dec;21(12):4102-4104. doi: 10.1111/ajt.16778. Epub 2021 Aug 26.
8
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy.亡羊补牢，犹未晚矣：一名肾移植受者在反复免疫刺激和单克隆抗体治疗后最终实现针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的血清学转换
Kidney Int. 2021 Nov;100(5):1131-1132. doi: 10.1016/j.kint.2021.08.018. Epub 2021 Aug 31.
9
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.COVID-19 感染肾移植受者体内存在有效的体液免疫活性证据。
Am J Transplant. 2020 Nov;20(11):3149-3161. doi: 10.1111/ajt.16261. Epub 2020 Oct 2.
10
Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients.肾移植受者对 SARS-CoV-2 的体液免疫反应良好，且与症状相关。
Am J Transplant. 2021 Dec;21(12):3926-3935. doi: 10.1111/ajt.16746. Epub 2021 Jul 19.
本文引用的文献
1
Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities.抗尖峰单克隆抗体在 COVID-19 肾移植受者中的应用：疗效、种族差异。
Am J Transplant. 2022 Feb;22(2):640-645. doi: 10.1111/ajt.16843. Epub 2021 Sep 30.
2
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.皮下注射 REGEN-COV 抗体组合以预防 COVID-19。
N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.
3
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.利用血清学筛查鉴定与 SARS-CoV-2 感染及肾移植患者结局相关的患者特征。
Transplantation. 2021 Jan 1;105(1):151-157. doi: 10.1097/TP.0000000000003526.
4
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.倾向得分法在观察性研究中减少混杂效应的介绍
Multivariate Behav Res. 2011 May;46(3):399-424. doi: 10.1080/00273171.2011.568786. Epub 2011 Jun 8.
Zotero 插件